If these trials confirm the findings, benralizumab could become the first new therapy approved for eosinophilic exacerbations ...

Nov. 27, 2024 — A recent trial finds an injection given during some asthma and COPD attacks is more effective than the current treatment of steroid tablets, reducing the need for further ...

GSK (GSK) stock in focus as its experimental drug depemokimab undergoes EU review for asthma and nasal polyps. Read more here ...

Of four treatment response measures recorded at 6 months of mepolizumab treatment, an Asthma Control Questionnaire score was ...

Regardless of sociodemographic or clinical characteristics, children with food allergy face a significant psychosocial burden ...

The family of a Wisconsin man is suing after they say he died from an asthma attack when his medication price rose from $66 ...

Intermediate group 2 innate lymphoid cells (ILC2s) appear to be able to get around cutting-edge asthma treatments by ...

Ethris announces promising phase 1 results for ETH47, its mRNA therapy for uncontrolled asthma. The inhaled treatment showed strong safety and efficacy, with plans for a phase 2 trial in 2025.

A Victorian-based company is using AI to help “map” and personalise the best treatment for patients with respiratory ...

Asthma is a chronic inflammatory disease that affects the lungs. In a child with asthma, the airways are very sensitive, ...

Although cost-related asthma treatment nonadherence has declined in the US, nearly 1 in 6 patients are still nonadherent due to cost concerns.

A simple, noninvasive nasal swab identified a predominance of T2-low asthma subtypes in racial and ethnic minority pediatric ...